Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-067013
Filing Date
2015-08-19
Accepted
2015-08-19 20:26:14
Documents
1
Period of Report
2015-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7332
  Complete submission text file 0001209191-15-067013.txt   8832
Mailing Address 61 HARTFORD STREET SAN FRANCISCO CA 94114
Business Address
HASTINGS PAUL J (Reporting) CIK: 0001309702 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 151065244

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations